INTO Study report

The INTO? Study: Report of Results

The INTO? study was a cross-sectional survey of gay and bisexual men (GBM) in Australia conducted between December 2019 and March 2020. INTO? examined recent sexual and drug use events, with a focus on how biomedical HIV prevention methods may affect the negotiation of sex and drug use practices. Focusing on specific events rather than behaviour over a period of time can be useful to understand the complexities and specifics of intentions, behaviours, and disclosure of HIV status as individuals negotiate sex with different partners.

Key findings
  • Among non-HIV-positive respondents, 22.3% reported not currently using PrEP and had anal sex without a condom with a casual partner in the last 6 months.
  • Among participants who had casual sex in the last 6 months, 17.6% reported having a ‘no condoms plus drug use’ event, 52.9% reported having a ‘no condoms plus no drug use’ event, 3.1% reported ‘condoms plus drug use’ event and 33.6% reported having a ‘condoms plus no drug use’ event.
  • Among all participants ‘drug use plus no sex’ was reported by 16.8% of participants.
  • 79.6% of ‘no condoms plus drug use’ events and 65.2% of ‘no condoms plus no drug use’ events were covered by either pre-exposure prophylaxis (PrEP) or treatment as prevention (TasP).